| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.54e-06 | 37 | 139 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOA3 KDM3A NCOA6 TOX CHD3 CHD4 CHD7 CHD1L ARID1B SCMH1 GLYR1 TOX3 SMARCA1 TSPYL5 NFAT5 TOX2 STAG3 | 1.54e-05 | 739 | 139 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | MYOT CDHR2 ECM2 SPTBN1 DAB2 TMOD3 EMILIN1 TENM4 NECTIN1 PRKCA DMD CDH10 ZC3HAV1 | 2.88e-04 | 599 | 139 | 13 | GO:0050839 |
| GeneOntologyBiologicalProcess | chromatin remodeling | NCOA3 KDM3A SETMAR DYRK1A CHD3 WDR5 CHD4 CHD7 CHD1L ARID1B UBR5 SCMH1 GLYR1 SMARCA1 PRKCA TSPYL5 NFAT5 | 1.16e-05 | 741 | 140 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | NCOA3 KDM3A SETMAR MED30 TOX DYRK1A CHD3 WDR5 CHD4 CHD7 CHD1L ARID1B UBR5 POLR1E SCMH1 GLYR1 SMARCA1 PRKCA TSPYL5 NFAT5 | 1.38e-05 | 999 | 140 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | NCOA3 KDM3A SETMAR TOX DYRK1A CHD3 WDR5 CHD4 CHD7 CHD1L ARID1B UBR5 SCMH1 GLYR1 SMARCA1 PRKCA TSPYL5 NFAT5 | 3.70e-05 | 896 | 140 | 18 | GO:0006325 |
| GeneOntologyCellularComponent | actin filament | 6.36e-05 | 146 | 142 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | procentriole | 1.37e-04 | 3 | 142 | 2 | GO:0120098 | |
| MousePheno | abnormal fetal cardiomyocyte proliferation | 3.93e-05 | 48 | 112 | 5 | MP:0003567 | |
| MousePheno | abnormal hearing physiology | TPO AGAP5 TRPA1 TOX MCIDAS DEPDC1 CHD7 MAP3K1 ZC3H7A CEP78 NEK5 SCMH1 PRRC2C PCDH15 COBL DMD | 5.17e-05 | 643 | 112 | 16 | MP:0001963 |
| MousePheno | abnormal auditory brainstem response | TPO AGAP5 TRPA1 TOX MCIDAS DEPDC1 CHD7 MAP3K1 ZC3H7A CEP78 SCMH1 PRRC2C PCDH15 COBL DMD | 5.43e-05 | 576 | 112 | 15 | MP:0004738 |
| MousePheno | abnormal fetal cardiomyocyte physiology | 7.63e-05 | 55 | 112 | 5 | MP:0011390 | |
| MousePheno | abnormal hearing electrophysiology | TPO AGAP5 TRPA1 TOX MCIDAS DEPDC1 CHD7 MAP3K1 ZC3H7A CEP78 SCMH1 PRRC2C PCDH15 COBL DMD | 7.69e-05 | 594 | 112 | 15 | MP:0006335 |
| MousePheno | abnormal ear physiology | TPO AGAP5 TRPA1 TOX MCIDAS DEPDC1 CHD7 MAP3K1 ZC3H7A CEP78 NEK5 SCMH1 PRRC2C PCDH15 COBL DMD | 1.07e-04 | 684 | 112 | 16 | MP:0003878 |
| Domain | SNF2_N | 3.39e-06 | 32 | 137 | 5 | IPR000330 | |
| Domain | SNF2_N | 3.39e-06 | 32 | 137 | 5 | PF00176 | |
| Domain | DEAH_ATP_HELICASE | 8.15e-06 | 38 | 137 | 5 | PS00690 | |
| Domain | HMG_box_dom | 1.15e-04 | 65 | 137 | 5 | IPR009071 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.22e-04 | 35 | 137 | 4 | IPR002464 | |
| Domain | CHD_N | 1.59e-04 | 3 | 137 | 2 | IPR012958 | |
| Domain | CHD_C2 | 1.59e-04 | 3 | 137 | 2 | IPR012957 | |
| Domain | CHDCT2 | 1.59e-04 | 3 | 137 | 2 | PF08074 | |
| Domain | CHDNT | 1.59e-04 | 3 | 137 | 2 | PF08073 | |
| Domain | DUF1086 | 1.59e-04 | 3 | 137 | 2 | IPR009462 | |
| Domain | DUF1087 | 1.59e-04 | 3 | 137 | 2 | IPR009463 | |
| Domain | DUF1087 | 1.59e-04 | 3 | 137 | 2 | PF06465 | |
| Domain | DUF1086 | 1.59e-04 | 3 | 137 | 2 | PF06461 | |
| Domain | DUF1087 | 1.59e-04 | 3 | 137 | 2 | SM01147 | |
| Domain | DUF1086 | 1.59e-04 | 3 | 137 | 2 | SM01146 | |
| Domain | Pecanex_C | 3.17e-04 | 4 | 137 | 2 | PF05041 | |
| Domain | CEBP_ZZ | 3.17e-04 | 4 | 137 | 2 | PF16366 | |
| Domain | RRM_7 | 3.17e-04 | 4 | 137 | 2 | PF16367 | |
| Domain | CEBP_ZZ | 3.17e-04 | 4 | 137 | 2 | IPR032296 | |
| Domain | Pecanex | 3.17e-04 | 4 | 137 | 2 | IPR007735 | |
| Domain | Chromo_domain | 6.98e-04 | 24 | 137 | 3 | IPR023780 | |
| Domain | - | 7.07e-04 | 55 | 137 | 4 | 1.10.30.10 | |
| Domain | Chromo | 8.87e-04 | 26 | 137 | 3 | PF00385 | |
| Domain | ZnF_UBR1 | 1.09e-03 | 7 | 137 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.09e-03 | 7 | 137 | 2 | PS51157 | |
| Domain | zf-UBR | 1.09e-03 | 7 | 137 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.09e-03 | 7 | 137 | 2 | IPR003126 | |
| Domain | CHROMO_1 | 1.11e-03 | 28 | 137 | 3 | PS00598 | |
| Domain | CHROMO_2 | 1.11e-03 | 28 | 137 | 3 | PS50013 | |
| Domain | Helicase_C | 1.15e-03 | 107 | 137 | 5 | PF00271 | |
| Domain | HELICc | 1.15e-03 | 107 | 137 | 5 | SM00490 | |
| Domain | Helicase_C | 1.20e-03 | 108 | 137 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.25e-03 | 109 | 137 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.25e-03 | 109 | 137 | 5 | PS51192 | |
| Domain | DEXDc | 1.25e-03 | 109 | 137 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.30e-03 | 110 | 137 | 5 | IPR014001 | |
| Domain | Chromodomain-like | 1.64e-03 | 32 | 137 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.79e-03 | 33 | 137 | 3 | IPR000953 | |
| Domain | CHROMO | 1.79e-03 | 33 | 137 | 3 | SM00298 | |
| Pubmed | 5.48e-08 | 83 | 143 | 7 | 28794006 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KDM3A NR2C2 ZNF148 SYNPO CHD3 WDR5 CHD4 CHD7 CHD1L POLR1E SCMH1 GLYR1 SMARCA1 RACGAP1 | 2.42e-07 | 608 | 143 | 14 | 36089195 |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 22496870 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NR2C2 ZNF148 NUP85 MTERF1 UBR4 DYRK1A DEPDC1 CHD4 CHD1L CUL7 UBR5 PRRC2C GLYR1 CBFA2T2 SMARCA1 XPO7 | 5.35e-07 | 857 | 143 | 16 | 25609649 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RBBP6 CHD3 WDR5 CHD4 CUL7 MAP3K1 ZC3H7A CEP78 POLR1E PRRC2C GLYR1 SCAPER RACGAP1 MTCH1 ZC3HAV1 | 6.11e-07 | 759 | 143 | 15 | 35915203 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 KDM3A NCOA6 ZNF148 RBBP6 SPTBN1 DAB2 CHD3 CHD4 CHD7 PNISR TBC1D9 MYO3A CBFA2T2 ZC3HAV1 | 7.79e-07 | 774 | 143 | 15 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBKBP1 SHB SYNPO CHD3 CEP192 CHD1L H6PD SUCLA2 PCNX2 USF3 GPR137C GLYR1 CBFA2T2 TOX3 PKD2 COBL PLA2G6 KATNIP NFAT5 ZC3HAV1 XPO7 | 8.26e-07 | 1489 | 143 | 21 | 28611215 |
| Pubmed | RBBP6 SPTBN1 DAB2 SYNPO SIK3 PNISR MADD ZC3H7A USF3 COBL DMD HERPUD1 | 8.81e-07 | 486 | 143 | 12 | 20936779 | |
| Pubmed | CEP192 MADD TENM4 ZBED4 UBR5 PRRC2C COBL DISP2 KATNIP NFAT5 XPO7 | 1.07e-06 | 407 | 143 | 11 | 12693553 | |
| Pubmed | 1.82e-06 | 268 | 143 | 9 | 33640491 | ||
| Pubmed | PLB1 NUP85 SPTBN1 TMOD3 WDR5 CHD4 EMILIN1 UBR5 POLR1E SCMH1 GLYR1 COBL DMD STAG3 | 3.04e-06 | 754 | 143 | 14 | 35906200 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 TBKBP1 NUP85 PCNX3 MTG2 UBR4 DYRK1A AMBRA1 CEP192 TBC1D9 MADD CABLES1 PCNX2 ZBED4 COBL PLA2G6 DISP2 | 3.23e-06 | 1105 | 143 | 17 | 35748872 |
| Pubmed | 4.18e-06 | 157 | 143 | 7 | 30186101 | ||
| Pubmed | NCOA3 NCOA6 NR2C2 ZNF148 RBBP6 SPTBN1 UBR4 TMOD3 CHD3 WDR5 CHD7 CEP192 CUL7 ARID1B PRRC2C GLYR1 SMARCA1 RACGAP1 ZC3HAV1 | 6.75e-06 | 1429 | 143 | 19 | 35140242 | |
| Pubmed | 1.03e-05 | 332 | 143 | 9 | 37433992 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.24e-05 | 123 | 143 | 6 | 26912792 | |
| Pubmed | ZNF148 UBR4 DAB2 SYNPO CUL7 SPAG5 FAM83B ARID1B UBR5 TSPYL5 ZC3HAV1 XPO7 | 1.32e-05 | 634 | 143 | 12 | 34591612 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.60e-05 | 351 | 143 | 9 | 38297188 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 1.68e-05 | 2 | 143 | 2 | 7560064 | |
| Pubmed | MYO3A Causes Human Dominant Deafness and Interacts with Protocadherin 15-CD2 Isoform. | 1.68e-05 | 2 | 143 | 2 | 26841241 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 7575689 | ||
| Pubmed | Cep78 is a new centriolar protein involved in Plk4-induced centriole overduplication. | 1.68e-05 | 2 | 143 | 2 | 27246242 | |
| Pubmed | PKC-α contributes to high NaCl-induced activation of NFAT5 (TonEBP/OREBP) through MAPK ERK1/2. | 1.68e-05 | 2 | 143 | 2 | 25391900 | |
| Pubmed | The histone demethylase Kdm3a is essential to progression through differentiation. | 1.68e-05 | 2 | 143 | 2 | 22581778 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 35111387 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 17487979 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 12697058 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 8758910 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 26959381 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 1.68e-05 | 2 | 143 | 2 | 35568926 | |
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 1.68e-05 | 2 | 143 | 2 | 8843877 | |
| Pubmed | NCOA3 RBBP6 AMBRA1 CHD3 WDR5 CHD4 SIK3 FAM83B UBR5 PRRC2C TSPYL5 ZC3HAV1 | 1.82e-05 | 655 | 143 | 12 | 35819319 | |
| Pubmed | 1.89e-05 | 13 | 143 | 3 | 9653646 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.99e-05 | 361 | 143 | 9 | 26167880 | |
| Pubmed | NCOA3 ZNF148 TOX ETS2 CHD3 MEIS2 ZBED4 GLYR1 ZNF655 TOX3 SCAPER NFAT5 ZC3HAV1 | 3.13e-05 | 808 | 143 | 13 | 20412781 | |
| Pubmed | SPTBN1 DYRK1A ST6GAL1 CHD3 DEPDC1 CHD7 CEP192 CUBN MADD SPAG5 ARID1B FMN1 GLYR1 ZNF655 NFAT5 | 4.30e-05 | 1084 | 143 | 15 | 11544199 | |
| Pubmed | SETMAR MTG2 DYRK1A AMBRA1 CHD1L SUCLA2 ABCB10 MAGED4 PRRC2C SMARCA1 ZC3HAV1 | 4.46e-05 | 606 | 143 | 11 | 36538041 | |
| Pubmed | Human Cep192 and Cep152 cooperate in Plk4 recruitment and centriole duplication. | 5.02e-05 | 3 | 143 | 2 | 23641073 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 20937770 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 32658897 | ||
| Pubmed | Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2. | 5.02e-05 | 3 | 143 | 2 | 21527521 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 17529974 | ||
| Pubmed | Silencing of the meiotic genes SMC1beta and STAG3 in somatic cells by E2F6. | 5.02e-05 | 3 | 143 | 2 | 16236716 | |
| Pubmed | UBR E3 ligases and the PDIA3 protease control degradation of unfolded antibody heavy chain by ERAD. | 5.02e-05 | 3 | 143 | 2 | 32558906 | |
| Pubmed | Megalin, cubilin, and Dab2 drive endocytic flux in kidney proximal tubule cells. | 5.02e-05 | 3 | 143 | 2 | 37126375 | |
| Pubmed | CPEB2, a novel putative translational regulator in mouse haploid germ cells. | 5.02e-05 | 3 | 143 | 2 | 12672660 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 24277814 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 22637477 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 17024188 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 22493235 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 32113875 | ||
| Pubmed | NR2C2 ZNF148 RBBP6 TMOD3 CHD3 WDR5 CHD4 GLYR1 CBFA2T2 RACGAP1 COBL NFAT5 ZC3HAV1 | 5.06e-05 | 847 | 143 | 13 | 35850772 | |
| Pubmed | ZNF148 RBBP6 TMOD3 AMBRA1 CHD3 CHD4 SIK3 CUL7 ARID1B HMCN2 UBR5 POLR1E CPEB4 SCAPER SMARCA1 | 5.96e-05 | 1116 | 143 | 15 | 31753913 | |
| Pubmed | 6.20e-05 | 418 | 143 | 9 | 34709266 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 7.70e-05 | 430 | 143 | 9 | 35044719 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 7.90e-05 | 248 | 143 | 7 | 27926873 | |
| Pubmed | NUP85 AMBRA1 CHD3 SIK3 MADD SPAG5 CEP78 PRRC2C RACGAP1 DBR1 ZC3HAV1 | 8.33e-05 | 650 | 143 | 11 | 38777146 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 NR2C2 ZNF148 RBBP6 CHD3 WDR5 CHD4 CHD7 CHD1L PNISR ZBED4 POLR1E GLYR1 RACGAP1 ZNF221 ZC3HAV1 | 8.91e-05 | 1294 | 143 | 16 | 30804502 |
| Pubmed | CPEB2-dependent translation of long 3'-UTR Ucp1 mRNA promotes thermogenesis in brown adipose tissue. | 1.00e-04 | 4 | 143 | 2 | 30177570 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 18437204 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 20417875 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 15611179 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 12871996 | ||
| Pubmed | A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons. | 1.00e-04 | 4 | 143 | 2 | 16055722 | |
| Pubmed | Meiotic cohesin STAG3 is required for chromosome axis formation and sister chromatid cohesion. | 1.00e-04 | 4 | 143 | 2 | 24797474 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 17997823 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 31235857 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 16574654 | ||
| Pubmed | Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development. | 1.00e-04 | 4 | 143 | 2 | 24064296 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 11210191 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 9326634 | ||
| Pubmed | Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis. | 1.00e-04 | 4 | 143 | 2 | 24997597 | |
| Pubmed | The substrate recognition domains of the N-end rule pathway. | 1.00e-04 | 4 | 143 | 2 | 19008229 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 21186323 | ||
| Pubmed | STIL binding to Polo-box 3 of PLK4 regulates centriole duplication. | 1.00e-04 | 4 | 143 | 2 | 26188084 | |
| Pubmed | Structural and Functional Analyses of the FAM46C/Plk4 Complex. | 1.00e-04 | 4 | 143 | 2 | 32433990 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | NUP85 TOX RBBP6 MTERF1 UBR4 CHD4 SUCLA2 PRRC2C TOX3 SMARCA1 ZC3HAV1 | 1.02e-04 | 665 | 143 | 11 | 30457570 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NCOA3 DAB2 DYRK1A WDR5 PNISR MAP3K1 MADD ZC3H7A CEP78 UBR5 KATNIP DBR1 DMD ZC3HAV1 | 1.02e-04 | 1038 | 143 | 14 | 26673895 |
| Pubmed | SLC25A21 MYOT TRPA1 ETS2 MEIS2 HHIP TENM4 PKD2 SMARCA1 GPAT2 STAG3 | 1.14e-04 | 674 | 143 | 11 | 37196079 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.31e-04 | 361 | 143 | 8 | 30344098 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.37e-04 | 271 | 143 | 7 | 32433965 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CWF19L2 RBBP6 SPTBN1 CHD4 CHD7 SIK3 PNISR ARID1B ZBED4 GLYR1 CPEB4 PCDH15 TSPYL5 MTCH1 | 1.58e-04 | 1082 | 143 | 14 | 38697112 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.58e-04 | 583 | 143 | 10 | 29844126 | |
| Pubmed | Performance of common genetic variants in breast-cancer risk models. | 1.67e-04 | 5 | 143 | 2 | 20237344 | |
| Pubmed | Identification and molecular characterization of the mammalian α-kleisin RAD21L. | 1.67e-04 | 5 | 143 | 2 | 21527826 | |
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 19232126 | ||
| Pubmed | Endocytosis of megalin by visceral endoderm cells requires the Dab2 adaptor protein. | 1.67e-04 | 5 | 143 | 2 | 16263760 | |
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 18355772 | ||
| Pubmed | Proteomic analysis of mouse thymoma EL4 cells treated with bis(tri-n-butyltin)oxide (TBTO). | 1.67e-04 | 5 | 143 | 2 | 19552622 | |
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 11788601 | ||
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 20940704 | ||
| Pubmed | A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons. | 1.67e-04 | 5 | 143 | 2 | 20639532 | |
| Pubmed | Anti-proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylase. | 1.67e-04 | 5 | 143 | 2 | 21336257 | |
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 30061390 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CWF19L2 TBKBP1 RBBP6 CHD7 CEP192 CUL7 FAM83B ZC3H7A UBR5 PRRC2C | 1.69e-04 | 588 | 143 | 10 | 38580884 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.71e-04 | 281 | 143 | 7 | 28706196 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.77e-04 | 377 | 143 | 8 | 38117590 | |
| Pubmed | NCOA3 SPTBN1 UBR4 DYRK1A SYNPO CHD4 CHD7 SIK3 UBR5 PRRC2C RACGAP1 PRKCA CDH10 | 1.81e-04 | 963 | 143 | 13 | 28671696 | |
| Pubmed | 2.07e-04 | 28 | 143 | 3 | 35474067 | ||
| Pubmed | 2.07e-04 | 28 | 143 | 3 | 29365100 | ||
| Interaction | NUP43 interactions | KDM3A NCOA6 NR2C2 NUP85 RBBP6 CHD3 WDR5 CCDC168 CUL7 SPAG5 ARID1B UBR5 POLR1E PRRC2C GLYR1 TOX3 SMARCA1 | 1.65e-06 | 625 | 140 | 17 | int:NUP43 |
| Interaction | PCNT interactions | C1orf87 SPTBN1 DYRK1A CHD3 CHD4 CEP192 PNISR MADD RACGAP1 PLK4 | 7.32e-06 | 241 | 140 | 10 | int:PCNT |
| Interaction | KIF2A interactions | 7.59e-06 | 242 | 140 | 10 | int:KIF2A | |
| Interaction | MEX3A interactions | TBKBP1 SPTBN1 CAMK2N2 CHD3 CHD4 ZC3H7A ABCB10 ZBED4 PRRC2C GLYR1 CPEB4 ZC3HAV1 | 1.57e-05 | 384 | 140 | 12 | int:MEX3A |
| Interaction | FMR1 interactions | NCOA3 TBKBP1 RBBP6 SPTBN1 UBR4 CHD3 CHD4 CHD7 SIK3 SPAG5 ZC3H7A PRRC2C CPEB4 ZC3HAV1 | 2.27e-05 | 536 | 140 | 14 | int:FMR1 |
| Interaction | TPR interactions | 2.76e-05 | 281 | 140 | 10 | int:TPR | |
| Interaction | H3C3 interactions | KDM3A NR2C2 ZNF148 CHD3 WDR5 CHD4 CHD7 CHD1L POLR1E SCMH1 GLYR1 SMARCA1 RACGAP1 | 4.26e-05 | 495 | 140 | 13 | int:H3C3 |
| Cytoband | 20q11 | 1.45e-04 | 6 | 144 | 2 | 20q11 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 4.20e-04 | 7 | 82 | 2 | 785 | |
| GeneFamily | Cohesin complex | 5.59e-04 | 8 | 82 | 2 | 1060 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.30e-03 | 12 | 82 | 2 | 1305 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 4.12e-07 | 171 | 142 | 9 | M39234 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | NCOA3 KDM3A TOX RBBP6 SPTBN1 ST6GAL1 CHD7 ST8SIA1 SIK3 MAP3K1 USF3 CCDC198 CDH10 ZC3HAV1 | 5.81e-07 | 498 | 142 | 14 | M1741 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | NCOA3 KDM3A TOX RBBP6 SPTBN1 ST6GAL1 CHD7 ST8SIA1 SIK3 MAP3K1 USF3 CCDC198 CDH10 ZC3HAV1 | 7.19e-07 | 507 | 142 | 14 | MM1030 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 1.05e-06 | 141 | 142 | 8 | M39235 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | KANSL1L CWF19L2 CUBN PNISR CCDC198 SCMH1 PRRC2C SCAPER PCDH15 | 3.46e-06 | 221 | 142 | 9 | M39222 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.86e-05 | 208 | 142 | 8 | M39233 | |
| Coexpression | CAFFAREL_RESPONSE_TO_THC_UP | 2.64e-05 | 32 | 142 | 4 | M11298 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | SCAMP4 SPTBN1 SQLE ETS2 SYNPO CHD3 CHD7 PNISR MEIS2 ZC3H7A UBR5 PRRC2C PKD2 PRKCA TSPYL5 | 2.65e-05 | 790 | 142 | 15 | M12490 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 3.49e-05 | 166 | 142 | 7 | M6826 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.95e-05 | 300 | 142 | 9 | M8702 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 5.14e-05 | 240 | 142 | 8 | M39236 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN | 9.97e-05 | 196 | 142 | 7 | M5008 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL6A3 RBBP6 SPTBN1 SHB DAB2 SYNPO CHD3 CHD4 CEP192 DNAAF9 ST8SIA1 CUBN PNISR CEP78 PRRC2C PRKCA CDH10 | 1.01e-04 | 1102 | 142 | 17 | M2369 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.04e-04 | 137 | 142 | 6 | M39241 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN | 1.13e-04 | 200 | 142 | 7 | M8110 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN | 1.13e-04 | 200 | 142 | 7 | M8278 | |
| Coexpression | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP | 1.20e-04 | 18 | 142 | 3 | M17700 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | TPO ZNF148 RBBP6 CHD4 NDUFA2 NPEPL1 MEIS2 HHIP TENM4 SCMH1 CTNS DMD | 1.26e-04 | 610 | 142 | 12 | M3854 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL6A3 RBBP6 SPTBN1 SHB DAB2 SYNPO CHD3 CHD4 CEP192 DNAAF9 ST8SIA1 CUBN PNISR CEP78 PRRC2C PRKCA CDH10 | 1.28e-04 | 1124 | 142 | 17 | MM1070 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | TPO ZNF148 RBBP6 CHD4 NDUFA2 NPEPL1 MEIS2 HHIP TENM4 SCMH1 CTNS DMD | 1.36e-04 | 615 | 142 | 12 | M8673 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | NCOA3 KDM3A NCOA6 NR2C2 ETS2 SIK3 CUL7 PNISR ZC3H7A CBFA2T2 CTNS NFAT5 HERPUD1 ZC3HAV1 | 1.57e-04 | 822 | 142 | 14 | M6782 |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.62e-04 | 212 | 142 | 7 | MM3816 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NCOA3 NR2C2 ZNF148 SPTBN1 CHD4 PNISR EMILIN1 MEIS2 MAP3K1 HHIP TENM4 SCMH1 PRRC2C CPEB4 PKD2 CTRL TOX2 GPAT2 STAG3 CDH10 SMC1B ZC3HAV1 | 8.96e-09 | 806 | 136 | 22 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NCOA3 NR2C2 CWF19L2 ZNF148 SPTBN1 PNISR EMILIN1 MEIS2 MAP3K1 TENM4 SCMH1 PRRC2C CPEB4 ZNF606 NFAT5 GPAT2 STAG3 CDH10 SMC1B | 9.21e-07 | 804 | 136 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | NR2C2 MYOT ZNF148 SPTBN1 CPEB3 SYNPO FAM241B PNISR PCNX2 TENM4 PRRC2C CPEB4 SCAPER TOX2 GPAT2 SMC1B ZC3HAV1 | 8.89e-06 | 770 | 136 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | KANSL1L NR2C2 ZNF148 SPTBN1 CPEB3 PNISR PCNX2 TENM4 SCMH1 PRRC2C CPEB4 SCAPER NFAT5 GPAT2 STAG3 SMC1B ZC3HAV1 | 1.02e-05 | 778 | 136 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | NR2C2 ZNF148 SPTBN1 PNISR MEIS2 TENM4 SCMH1 CPEB4 NFAT5 GPAT2 STAG3 CDH10 | 1.31e-05 | 409 | 136 | 12 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | NR2C2 ZNF148 SPTBN1 CPEB3 PNISR MAP3K1 PCNX2 TENM4 SCMH1 PRRC2C CPEB4 PKD2 NFAT5 GPAT2 STAG3 SMC1B ZC3HAV1 | 1.34e-05 | 795 | 136 | 17 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | NCOA3 NR2C2 ZNF148 SPTBN1 CPEB3 PNISR MEIS2 MADD GPR137C SCMH1 CPEB4 SCAPER NFAT5 GPAT2 STAG3 SMC1B | 3.81e-05 | 776 | 136 | 16 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NCOA3 NR2C2 ZNF148 SPTBN1 DAB2 TMOD3 PNISR EMILIN1 MEIS2 MAP3K1 TENM4 SCMH1 PRRC2C CPEB4 PKD2 NFAT5 | 5.55e-05 | 801 | 136 | 16 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | COL6A3 CWF19L2 TOX RBBP6 SYNPO CHD7 MEIS2 MADD SPAG5 ZC3H7A UBR5 GPR137C TOX3 SCAPER CD68 KATNIP DMD TOX2 | 5.73e-05 | 983 | 136 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NCOA3 NR2C2 ZNF148 SPTBN1 TMOD3 DEPDC1 CHD7 PNISR MEIS2 TENM4 SCMH1 PRRC2C CPEB4 TOX3 ZNF606 CDH10 | 6.81e-05 | 815 | 136 | 16 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.59e-05 | 277 | 136 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | NR2C2 CPEB3 PNISR MADD GPR137C SCMH1 CPEB4 GPAT2 STAG3 SMC1B | 1.80e-04 | 382 | 136 | 10 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.82e-04 | 311 | 136 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.91e-04 | 246 | 136 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | ZNF148 SPTBN1 CPEB3 PNISR TENM4 SCMH1 CPEB4 GPAT2 STAG3 SMC1B | 2.00e-04 | 387 | 136 | 10 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | NR2C2 ZNF148 SPTBN1 PNISR SCMH1 CPEB4 NFAT5 GPAT2 STAG3 SMC1B | 2.00e-04 | 387 | 136 | 10 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.41e-04 | 323 | 136 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.43e-04 | 255 | 136 | 8 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.70e-04 | 259 | 136 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NR2C2 CWF19L2 TOX RBBP6 SQLE CHD7 MEIS2 MADD SPAG5 UBR5 GPR137C TOX3 DMD | 3.00e-04 | 654 | 136 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NCOA3 NR2C2 ZNF148 SPTBN1 PNISR EMILIN1 MEIS2 TENM4 SCMH1 PRRC2C | 3.35e-04 | 413 | 136 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.03e-04 | 275 | 136 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.16e-04 | 210 | 136 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CWF19L2 TOX DEPDC1 CHD7 CEP192 ST8SIA1 TBC1D9 TULP1 MADD SPAG5 ZBED4 CBFA2T2 TOX3 DBR1 DMD ZNF606 PLK4 | 4.44e-04 | 1060 | 136 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | NR2C2 TOX MTERF1 SQLE CHD3 CHD7 SLC22A17 MEIS2 MADD GPR137C TOX3 DMD TOX2 | 4.53e-04 | 683 | 136 | 13 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | KANSL1L TOX LRRC37A3 DYRK1A AMBRA1 SIK3 ARID1B SCMH1 FMN1 SCAPER PRKCA DMD | 2.17e-12 | 198 | 143 | 12 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | KANSL1L TOX LRRC37A3 DYRK1A AMBRA1 SIK3 ARID1B SCMH1 SCAPER PRKCA DMD | 4.23e-11 | 196 | 143 | 11 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | LRRC37A3 CPEB3 DYRK1A AMBRA1 SIK3 ARID1B UBR5 SCMH1 SCAPER PRKCA DMD | 4.98e-11 | 199 | 143 | 11 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.75e-08 | 166 | 143 | 8 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-06 | 172 | 143 | 7 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-06 | 176 | 143 | 7 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-06 | 176 | 143 | 7 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 1.86e-06 | 179 | 143 | 7 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-06 | 188 | 143 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 190 | 143 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-06 | 190 | 143 | 7 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-06 | 192 | 143 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.06e-06 | 193 | 143 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.28e-06 | 195 | 143 | 7 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 197 | 143 | 7 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.51e-06 | 197 | 143 | 7 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 197 | 143 | 7 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-06 | 198 | 143 | 7 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-05 | 164 | 143 | 6 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 165 | 143 | 6 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.68e-05 | 167 | 143 | 6 | 9280558baddea51aae47f3383d895a9b0c6749a4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 170 | 143 | 6 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 177 | 143 | 6 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 180 | 143 | 6 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-05 | 180 | 143 | 6 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 180 | 143 | 6 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 180 | 143 | 6 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 181 | 143 | 6 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 143 | 6 | a305667cfdae50e64e1890f10f71b407ae617b80 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 185 | 143 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.08e-05 | 186 | 143 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.08e-05 | 186 | 143 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-05 | 186 | 143 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-05 | 188 | 143 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 188 | 143 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 189 | 143 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.36e-05 | 189 | 143 | 6 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | 1924af7d8b0a0b892e480a9fd6d874941b0c0b5d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | 88f91e57a1409bdeb91e9bf47510a6fb998a1bf5 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.57e-05 | 191 | 143 | 6 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.67e-05 | 192 | 143 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 193 | 143 | 6 | 7cc10e8b51091869d46e462f3214999e7b5348b1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 193 | 143 | 6 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.78e-05 | 193 | 143 | 6 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.78e-05 | 193 | 143 | 6 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.89e-05 | 194 | 143 | 6 | 2b61023a602d336ed0de174e9141046173db34e6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 194 | 143 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_intermediate|COVID-19_Mild / Disease group, lineage and cell class | 3.89e-05 | 194 | 143 | 6 | bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 194 | 143 | 6 | f76808666fb875fc787751cbfd924d9be20a8192 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.89e-05 | 194 | 143 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 194 | 143 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.89e-05 | 194 | 143 | 6 | f2486b19ac52a48d19f80b38a5536bee3dad745b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 194 | 143 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 194 | 143 | 6 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.89e-05 | 194 | 143 | 6 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 194 | 143 | 6 | f5706ab6bc803606c4640ddd606617e4e797ccc9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 194 | 143 | 6 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.01e-05 | 195 | 143 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-05 | 195 | 143 | 6 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-05 | 196 | 143 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-05 | 196 | 143 | 6 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.12e-05 | 196 | 143 | 6 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-05 | 196 | 143 | 6 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-05 | 196 | 143 | 6 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-05 | 196 | 143 | 6 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-05 | 196 | 143 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.12e-05 | 196 | 143 | 6 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | mild_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 4.24e-05 | 197 | 143 | 6 | e909b898b7458071f176b6c04356ea3540589153 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 198 | 143 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 198 | 143 | 6 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-05 | 198 | 143 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 198 | 143 | 6 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.48e-05 | 199 | 143 | 6 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate|COVID-19_Mild / Disease, condition lineage and cell class | 4.48e-05 | 199 | 143 | 6 | 1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.48e-05 | 199 | 143 | 6 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-05 | 199 | 143 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | distal-1-Endothelial-Artery|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.48e-05 | 199 | 143 | 6 | fd71d08f6de790a29c880d50d2ed0881952d7791 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.61e-05 | 200 | 143 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 4.61e-05 | 200 | 143 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.36e-05 | 64 | 143 | 4 | bf923a66b17e717b8d3817b9d0e201b82a7e4a88 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.36e-05 | 64 | 143 | 4 | a3e852600c53b11175eb579e92962fa711f5678b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.36e-05 | 64 | 143 | 4 | f8f43ad9354c786b418bac54614f96f50e8bea68 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.76e-05 | 132 | 143 | 5 | 9633653dba1edee47d915212fb6e68426da49de5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.52e-05 | 135 | 143 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.52e-05 | 135 | 143 | 5 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.20e-04 | 149 | 143 | 5 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 79 | 143 | 4 | cc17a013a4a57a99c404b10449ef61ce559631d1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 79 | 143 | 4 | 19fb2bc964589ea40e7b9f0809c641331c93dacd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 151 | 143 | 5 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 156 | 143 | 5 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 1.48e-04 | 156 | 143 | 5 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 156 | 143 | 5 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 159 | 143 | 5 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 159 | 143 | 5 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 161 | 143 | 5 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 163 | 143 | 5 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.93e-04 | 165 | 143 | 5 | 1c630f9ecde2e0243922a2be4b1ab5adcfcb0893 | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 2.04e-04 | 167 | 143 | 5 | 82739226347d74897be000f429b73543a031af96 | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue | 2.04e-04 | 167 | 143 | 5 | dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 167 | 143 | 5 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| Computational | Neighborhood of PTPRB | TPO CPEB3 ST8SIA1 MAP3K1 TENM4 ABCB10 NPFF PRKCA DMD CTRL NFAT5 | 4.70e-06 | 254 | 85 | 11 | MORF_PTPRB |
| Computational | Neighborhood of PRKCA | 1.22e-05 | 181 | 85 | 9 | MORF_PRKCA | |
| Computational | Neighborhood of MAGEA9 | ECM2 CPEB3 ST8SIA1 SLC13A2 MAP3K1 TENM4 ABCB10 NPFF SCAPER PRKCA DMD CTRL NFAT5 | 2.52e-05 | 423 | 85 | 13 | MORF_MAGEA9 |
| Computational | Neighborhood of MAGEA8 | 3.66e-05 | 260 | 85 | 10 | MORF_MAGEA8 | |
| Computational | Neighborhood of SUPT3H | ECM2 CPEB3 ST8SIA1 MAP3K1 TENM4 ABCB10 NPFF PRKCA DMD CTRL NFAT5 | 5.13e-05 | 328 | 85 | 11 | MORF_SUPT3H |
| Computational | Neighborhood of MDM2 | 6.64e-05 | 279 | 85 | 10 | MORF_MDM2 | |
| Computational | Neighborhood of FSHR | 6.64e-05 | 279 | 85 | 10 | MORF_FSHR | |
| Computational | Neighborhood of MLLT10 | 1.28e-04 | 302 | 85 | 10 | MORF_MLLT10 | |
| Computational | Neighborhood of ERCC4 | 2.11e-04 | 321 | 85 | 10 | MORF_ERCC4 | |
| Computational | Neighborhood of RAD51L3 | ECM2 CPEB3 ST8SIA1 MAP3K1 TENM4 ABCB10 NPFF PRKCA DMD CTRL NFAT5 | 2.22e-04 | 387 | 85 | 11 | MORF_RAD51L3 |
| Computational | Neighborhood of ATF2 | 2.63e-04 | 330 | 85 | 10 | MORF_ATF2 | |
| Computational | Neighborhood of CAMK4 | 4.57e-04 | 290 | 85 | 9 | MORF_CAMK4 | |
| Drug | Methylatropine nitrate [52-88-0]; Down 200; 11uM; MCF7; HT_HG-U133A | SLC25A21 SQLE SHB ETS2 SLC22A17 SCMH1 SCAPER COBL CTNS CDH10 | 4.44e-07 | 199 | 140 | 10 | 6495_DN |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.30e-06 | 194 | 140 | 9 | 5880_UP | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; PC3; HT_HG-U133A | 3.44e-06 | 195 | 140 | 9 | 5760_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 4.06e-06 | 199 | 140 | 9 | 3128_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.20e-05 | 188 | 140 | 8 | 4845_DN | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; PC3; HT_HG-U133A | 2.85e-05 | 195 | 140 | 8 | 6303_UP | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | 2.96e-05 | 196 | 140 | 8 | 4238_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.07e-05 | 197 | 140 | 8 | 6310_UP | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; HL60; HT_HG-U133A | 3.07e-05 | 197 | 140 | 8 | 3132_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 3.18e-05 | 198 | 140 | 8 | 6287_DN | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; HL60; HG-U133A | 3.18e-05 | 198 | 140 | 8 | 1733_UP | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.30e-05 | 199 | 140 | 8 | 3274_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.30e-05 | 199 | 140 | 8 | 1482_UP | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 3.30e-05 | 199 | 140 | 8 | 7184_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; PC3; HT_HG-U133A | 3.42e-05 | 200 | 140 | 8 | 6321_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.42e-05 | 200 | 140 | 8 | 3833_UP | |
| Drug | (Z)-7-[(1R,2R,3R)-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-3-methyl-5-oxocyclopentyl]hept-5-enoic acid | 4.88e-05 | 33 | 140 | 4 | CID009548573 | |
| Disease | Malignant neoplasm of breast | NCOA3 KDM3A NCOA6 C1orf87 UBR4 ETS2 NDUFA2 SIK3 H6PD CUBN TEK MAP3K1 ARID1B ABCB10 TOX3 DMD CDH10 | 1.17e-05 | 1074 | 138 | 17 | C0006142 |
| Disease | breast carcinoma | SLC25A21 MED30 CPEB3 CEP192 SIK3 MEIS2 MAP3K1 MADD CABLES1 FAM83B ARID1B TOX3 PKD2 PLA2G6 DMD | 8.90e-05 | 1019 | 138 | 15 | EFO_0000305 |
| Disease | C-reactive protein measurement | LRRC3C NCOA6 CWF19L2 SIGLEC9 DYRK1A CCDC168 CHD7 CEP192 NPEPL1 MAP3K1 MADD ZNF655 PCDH15 PLA2G6 NFAT5 HERPUD1 | 1.70e-04 | 1206 | 138 | 16 | EFO_0004458 |
| Disease | Anemia, Megaloblastic | 2.15e-04 | 5 | 138 | 2 | C0002888 | |
| Disease | Duchenne muscular dystrophy (is_marker_for) | 2.15e-04 | 5 | 138 | 2 | DOID:11723 (is_marker_for) | |
| Disease | intellectual disability (is_implicated_in) | 3.70e-04 | 30 | 138 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | executive function measurement | 4.07e-04 | 376 | 138 | 8 | EFO_0009332 | |
| Disease | Usher Syndrome, Type III | 4.49e-04 | 7 | 138 | 2 | C1568248 | |
| Disease | response to risperidone | 7.49e-04 | 38 | 138 | 3 | GO_0097336 | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0800517 | |
| Disease | rectum cancer (is_implicated_in) | 7.65e-04 | 9 | 138 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | serum IgG glycosylation measurement | 8.20e-04 | 523 | 138 | 9 | EFO_0005193 | |
| Disease | chronic kidney disease | 8.58e-04 | 235 | 138 | 6 | EFO_0003884 | |
| Disease | Muscle Weakness | 9.53e-04 | 10 | 138 | 2 | C0151786 | |
| Disease | albuminuria | 1.01e-03 | 94 | 138 | 4 | EFO_0004285 | |
| Disease | cleft palate (is_implicated_in) | 1.39e-03 | 12 | 138 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Coffin-Siris syndrome | 1.64e-03 | 13 | 138 | 2 | C0265338 | |
| Disease | brain cortex volume measurement | 1.64e-03 | 13 | 138 | 2 | EFO_0010287 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.67e-03 | 50 | 138 | 3 | EFO_0022334 | |
| Disease | Early Pregnancy Loss | 1.74e-03 | 109 | 138 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 1.74e-03 | 109 | 138 | 4 | C0000786 | |
| Disease | Miscarriage | 1.74e-03 | 109 | 138 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 1.74e-03 | 109 | 138 | 4 | C0000822 | |
| Disease | sitting height ratio | 1.77e-03 | 51 | 138 | 3 | EFO_0007118 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 1.80e-03 | 110 | 138 | 4 | EFO_0003095, MONDO_0005148 | |
| Disease | cholesterol to total lipids in large HDL percentage | 2.20e-03 | 55 | 138 | 3 | EFO_0022234 | |
| Disease | colorectal cancer | 2.21e-03 | 604 | 138 | 9 | MONDO_0005575 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.31e-03 | 56 | 138 | 3 | EFO_0022235 | |
| Disease | ankle brachial index | 2.50e-03 | 16 | 138 | 2 | EFO_0003912 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 2.69e-03 | 59 | 138 | 3 | EFO_0022248 | |
| Disease | eosinophil percentage of leukocytes | PLB1 DYRK1A ST6GAL1 CHD7 SIK3 H6PD TULP1 CABLES1 TOX2 ZC3HAV1 | 2.73e-03 | 746 | 138 | 10 | EFO_0007991 |
| Disease | birth weight | 2.80e-03 | 399 | 138 | 7 | EFO_0004344 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.82e-03 | 60 | 138 | 3 | EFO_0022330 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 2.82e-03 | 60 | 138 | 3 | EFO_0022282 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.82e-03 | 17 | 138 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | cancer | 2.83e-03 | 400 | 138 | 7 | MONDO_0004992 | |
| Disease | red blood cell density measurement | SPTBN1 CHD4 SIK3 ARID1B CEP78 UBR5 FMN1 CPEB4 PLA2G6 CTRL XPO7 | 2.90e-03 | 880 | 138 | 11 | EFO_0007978 |
| Disease | melanoma | 2.95e-03 | 126 | 138 | 4 | EFO_0000756 | |
| Disease | ischemia (biomarker_via_orthology) | 3.16e-03 | 18 | 138 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | nevus count | 3.16e-03 | 18 | 138 | 2 | EFO_0004632 | |
| Disease | choline measurement | 3.30e-03 | 130 | 138 | 4 | EFO_0010116 | |
| Disease | Tinnitus | 3.30e-03 | 130 | 138 | 4 | HP_0000360 | |
| Disease | diet measurement, HOMA-B | 3.52e-03 | 19 | 138 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | total lipids in very large HDL measurement | 3.69e-03 | 66 | 138 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 3.69e-03 | 66 | 138 | 3 | EFO_0022298 | |
| Disease | cholesterol in very large HDL measurement | 4.19e-03 | 69 | 138 | 3 | EFO_0022229 | |
| Disease | Nonorganic psychosis | 4.19e-03 | 69 | 138 | 3 | C0349204 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PALSFSQRIVNGENA | 26 | P40313 | |
| QQAGARLGAAQSPFN | 51 | Q96D05 | |
| RLGAAQSPFNDLNRQ | 56 | Q96D05 | |
| EQAASANKPNFRGTR | 726 | Q5JQC9 | |
| NAVAFIRNFPQGFNT | 611 | Q9NRK6 | |
| QAAANSAQSRQGSFP | 1021 | Q8NFD5 | |
| NNLGVPATEQRQESF | 631 | Q5JTW2 | |
| EQLNNSFPSSRGRNT | 3661 | P11532 | |
| QNRPVAANTLDFGQN | 681 | Q13627 | |
| DQGLLNRPSAFSTVQ | 361 | Q9C0C7 | |
| RAPQSQNGNPSASEF | 341 | Q8N7E2 | |
| FAQNRGAGNTSSLNP | 2131 | Q9P2D1 | |
| AALVLQFQTNFRNSP | 901 | A7MBM2 | |
| NSSRFLDGNIPSQAN | 106 | Q8N0U7 | |
| ARSIPAFQALGQDCN | 401 | P49116 | |
| APAALGKVFNNSASQ | 496 | Q68DA7 | |
| NISRPEAAQQAFQGL | 141 | Q15011 | |
| LDANQLASVPAGAFQ | 86 | A6NJW4 | |
| NASLRDLQAPLGQSF | 261 | P34810 | |
| QASFLPENAFSANLN | 271 | P98082 | |
| GLQANRNTFAEQPST | 136 | Q9BQT8 | |
| FADQAASLNILGNPQ | 431 | A0AUZ9 | |
| QGAFSSLRDLSPQEN | 1356 | O60309 | |
| PQGRSSNSSENQQFL | 931 | Q8WXG6 | |
| DANRPSTAFLGQNDV | 221 | Q96JG8 | |
| NGINSARFFANPVSR | 486 | Q8WWW8 | |
| AFSPAGQQARDFQLR | 1511 | Q8NDA2 | |
| NNIAAFPDSVNSLEG | 1436 | O60303 | |
| QSNRAGFLLDPSVSQ | 341 | O14770 | |
| FFRAQRLNQNLAPAG | 321 | Q8N3F9 | |
| AGDASAPRFNTEQIQ | 881 | Q5T0W9 | |
| LSNDSQREFNSRPGT | 416 | O43439 | |
| RDPGNDDNNLNSIFY | 1376 | A6NKB5 | |
| RNPGADDNNLNSIFY | 1331 | Q9H6A9 | |
| IAAKDPANGRQFSSQ | 121 | Q9BW27 | |
| LQFQASAGDSDPQSR | 6 | Q8NDH3 | |
| QGALFGNLSTANPRQ | 301 | P07202 | |
| PNIVAFFNSFQENGR | 61 | Q6P3R8 | |
| SNPRQNQEFSFGNLR | 351 | Q2TBE0 | |
| FNILQNSSSELFGPR | 1176 | Q14999 | |
| QDFPGSNLNLLTNNS | 256 | P15036 | |
| RFLEAPVSGNQQLSN | 381 | Q49A26 | |
| NVDDNNQLFRFPATS | 96 | Q5TB30 | |
| ASFNGNREEADNPNT | 196 | Q8IVB5 | |
| QDRGFPVSFQSQSQL | 511 | P18054 | |
| QTNTVAQEAFFAAPN | 1151 | O94916 | |
| FAGPQAQQAAREVNT | 16 | Q96HR3 | |
| LAFPQGNAFTIRTAN | 361 | D6RGH6 | |
| AAGAQPRPSANRENF | 846 | Q7Z6E9 | |
| SFSENGFIHSPRNNQ | 26 | P0DTF9 | |
| SEGQSAAQSNARPQF | 1641 | Q14686 | |
| LGNFNNLFRITSNGS | 756 | Q96QU1 | |
| DFLEVRNGSNSNSPL | 3451 | O60494 | |
| NPATFQRSAGLQGSN | 381 | P0CG12 | |
| DRNDNAPVFQNTAFS | 116 | Q9BYE9 | |
| PVSNNNSGFLRNLLN | 876 | Q9Y4C1 | |
| QFLLPTNAFGARRNT | 401 | Q8TDN4 | |
| NAFRTDNGNNLLPFQ | 321 | Q8NE35 | |
| FSLAAVNPNFTVQDN | 526 | Q9Y6N8 | |
| QEAIDRFNAPGAQQF | 1116 | Q12873 | |
| SDFNPQNDLQAAARA | 441 | Q86WJ1 | |
| QFGVAPFTIARNADQ | 1361 | P12111 | |
| PVDSGLFSNRNNNAG | 551 | O75128 | |
| PLSENNQVQSGRAFH | 211 | Q14534 | |
| FAQAAAFLRQGQLPD | 701 | Q6NUI2 | |
| TRENLNAGNFNFPSE | 296 | Q5TEA3 | |
| EGNNLSEANVNPLAF | 446 | O94769 | |
| NNNRPSGISERFSAS | 71 | A0A075B6I4 | |
| TESLQGQDLFNRASP | 136 | Q8TEP8 | |
| GQDLFNRASPLEQAQ | 141 | Q8TEP8 | |
| FRQEVENNTLGSPAA | 196 | Q9UK59 | |
| PAAFINNNTAANGSS | 41 | Q17RY0 | |
| TAFNGRQQPADAAAR | 216 | Q9Y6C2 | |
| NGVNPVNSNDVFFSL | 196 | O60931 | |
| ISVQAQDSFPGQNAF | 291 | Q8NDH2 | |
| SSGRLFFSQQQPEQL | 516 | O95479 | |
| PSAGRVDFAFNQNLE | 26 | Q9NVL8 | |
| QEAIDRFNAPGAQQF | 1106 | Q14839 | |
| NSLFPQNGNVVNFAS | 251 | Q13183 | |
| REAQYNNFSGNSLPE | 201 | Q969E2 | |
| FDNNRQDPTGLTAAL | 1161 | Q9BY12 | |
| QPLAGSRRNQESNFN | 526 | Q13233 | |
| FGQETNVPLNNFSAD | 71 | O43678 | |
| APDGSQRAVLVQFSN | 16 | Q9GZS1 | |
| DQNPGSQFSQALAIR | 296 | Q9NZJ7 | |
| AAQFNGNEKRQSSPS | 351 | Q15464 | |
| GSNNSSPVDFVNNKR | 61 | Q96R06 | |
| LGQREAIEAFNAPNS | 551 | P28370 | |
| GNPNRDLNEAAITTF | 401 | Q8WUG5 | |
| PGNDSTASQDVANRF | 6 | P17252 | |
| ASNFQQEPAPRDRAS | 671 | Q8N3V7 | |
| PSGNLARNSSFSQQQ | 1366 | Q9Y6Q9 | |
| NSQFQQEFPSLQAAG | 136 | Q9Y520 | |
| NINNAFGPGTANERT | 371 | Q53H47 | |
| AEFTCRAQNPLGSQQ | 316 | Q9Y336 | |
| DVGANQTVLFANPNF | 241 | Q92185 | |
| SQFQGLPSRSAIFQQ | 766 | Q9Y2K2 | |
| DAVLRFNGAPTANFQ | 206 | P15907 | |
| GNRFFLANNNRAPVT | 191 | Q9H4K7 | |
| NPRNSQSGFRLFQLE | 61 | O60733 | |
| GDANDTNAFLNQAVP | 806 | Q6P1J6 | |
| SQAFLFQPQRFGRNT | 66 | O15130 | |
| SGSFERPDNNQALSN | 441 | O00444 | |
| AFLNRGQPSSSNAGN | 126 | Q9H0H5 | |
| FGDRNGNFLTLQQSP | 511 | Q96QV1 | |
| RAAAQVLGSSGLFNN | 26 | Q9P2R7 | |
| NLRSDNLFGNQPFTQ | 456 | Q96GD3 | |
| NQRLVSQDNFGFDLP | 441 | Q01082 | |
| LPNERSFQNAAKSNN | 66 | A6NHY2 | |
| QRNSQTDALEFNPSA | 91 | A6NIR3 | |
| VRIFNTNSSFQDQAP | 31 | Q5SQS8 | |
| QDTNSFFAGNQAKRP | 31 | Q96S95 | |
| GNRFTVFDNGQNPQR | 376 | O00294 | |
| FLLSRGANPNLRNFN | 116 | O75762 | |
| NQFQAFTQPATDGLS | 106 | Q6ZSR9 | |
| LQGNSPDSEASRQRF | 26 | Q9NX65 | |
| ARRFALSFGPQQLQN | 961 | Q9UJ98 | |
| RNNSAQAFLSPENPE | 1086 | Q8NDV3 | |
| ERQFNLNGNSVPTAT | 446 | Q6ZT07 | |
| ISQGAFSNPNAAAQV | 276 | P20061 | |
| QPALATFRALNESGN | 116 | A6NDX5 | |
| ERSPESFFRSNNNLN | 161 | Q99551 | |
| SINSLNRGNFTPRSN | 196 | Q6N022 | |
| NRSGNQRQSTVFDPS | 1996 | Q68DE3 | |
| FRDTQAAIKGQNPNA | 266 | O15405 | |
| EPAVQFNSGTLALNR | 791 | Q02763 | |
| QPSNQTEADNRSFIF | 296 | Q13563 | |
| SENFLGISSQPRNDF | 401 | Q8IWR0 | |
| AQEAAGSPRVQFQSL | 6 | Q8N720 | |
| ENFRNLLSVGNQPFH | 61 | Q9UK13 | |
| FRDTQAAIKGQNPSA | 266 | Q96NM4 | |
| NRSQRLQFDVSSPNG | 781 | Q9UIA9 | |
| SGEFAPDNRHIFNQN | 131 | Q8TF01 | |
| PLFNNNADGVATDIT | 426 | Q7Z2W4 | |
| FSEFPLVNVNDNRAG | 766 | Q9UQR1 | |
| REELQNQANFSFAPL | 1796 | Q5T4S7 | |
| QQQGLQDAAFSNLSP | 171 | A7MCY6 | |
| FFRDTQAAIKGQNPN | 271 | O94900 | |
| NFNPQSNLIVSGSFD | 136 | P61964 | |
| ENNFPTSSIAFLGQN | 781 | O95071 | |
| GAEFSQNLNFVPSQR | 216 | Q8WXB4 | |
| QFTQQGPRTRAANAI | 321 | Q9NYL9 | |
| LQSLSQGNPENNRSF | 336 | Q86VY4 | |
| LSPRLFESGAIFQQN | 436 | O75132 | |
| SANERFISAPNNKGS | 1146 | Q8NEV4 | |
| AFNPEGEFQRLAAQS | 476 | Q9UBF9 | |
| FATFPTGNRESQLNL | 126 | Q15223 |